A Multicenter, Phase I, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Etirinotecan Pegol in Patients with Refractory Solid Tumors Article

Industry Collaboration

cited authors

  • Jameson, Gayle S.; Hamm, John T.; Weiss, Glen J.; Alemany, Carlos; Anthony, Stephen; Basche, Michele; Ramanathan, Ramesh K.; Borad, Mitesh J.; Tibes, Raoul; Cohn, Allen; Hinshaw, Ioana; Jotte, Robert; Rosen, Lee S.; Hoch, Ute; Eldon, Michael A.; Medve, Robert; Schroeder, Katrina; White, Erica; Von Hoff, Daniel D.

authors

Publication Date

  • January 1, 2013

webpage

published in

category

start page

  • 268

end page

  • 278

volume

  • 19

issue

  • 1